NCT06475937
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06475937
Title A Study of DM001 in Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Sarah Cannon Research Institute (SCRI) Nashville Tennessee 37203 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Icon Cancer Centre South Brisbane South Brisbane Queensland 4101 Australia Details
Tasman Oncology Research Southport Queensland 4215 Australia Details
Monash Health Clayton Victoria 3168 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field